How Is SPRAVATO® Administered?
SPRAVATO® is administered as a nasal spray in a certified medical office under the supervision of a healthcare provider. After a treatment-resistant depression assessment, your provider will determine whether SPRAVATO® is appropriate for you. If you’re a candidate, a personalized care plan will be developed to guide your treatment. During each session, the medication is self-administered under clinical observation, and patients remain on-site for a few hours for monitoring before being cleared to leave. This structured approach ensures safety and supports the effectiveness of your ongoing care.